ICG makes public-to-private CV play in TowerBrook, CD&R de-listing deal

The $1.2bn secondaries transaction involves R1 RCM, a healthcare sector revenue cycle management services provider.

SECONDARIES INVESTOR

Register to unlock this content

• Daily global secondaries market news and intelligence
• Curated insights to keep you ahead of GP-led and LP-led secondaries
• Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
• Access to proprietary research and reports
• Selected fund performance and investor activity data

Register nowFind out more

DealsNorth AmericaHealthcareSingle AssetsFeaturedGP-LedsPEI Group Data